Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer

Molecular and Cellular Biochemistry

Volumn 369, Issue 1-2, 2012, Pages 217-225

  Sobti, Ranbir Chander ^a   Askari, Marjan ^a   Nikbakht, Mohsen ^b   Singh, Neha ^a   Sharma, Suresh C ^b   Abitew, Abayneh Munshea ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Breast cancer; EGFR; ESR; Polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RISK; CODON; CONTROLLED STUDY; DIABETES MELLITUS; ETHNICITY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREMENOPAUSE; RACE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS;

EID: 84865636765     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1384-x     Document Type: Article

References (58)

1. SE Shackney JF Silverman 2003 Molecular evolutionary patterns in breast cancer Adv Anat Pathol 10 5 278 290 12973049 10.1097/00125480-200309000-00003 1:CAS:528:DC%2BD3sXnvVSqs78%3D
2. I Persson 2000 Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings J Steroid Biochem Mol Biol 74 5 357 364 11162945 10.1016/S0960-0760(00)00113-8 1:CAS:528:DC%2BD3MXitFyisw%3D%3D (Pubitemid 32126247)
3. H Iwase JM Greenman DM Barnes, et al. 1996 Sequence variants of the estrogen receptor(ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors Cancer Lett 108 179 184 8973592 10.1016/S0304-3835(96)04406-0 1:CAS:528:DyaK28XntFWqtLY%3D (Pubitemid 26413520)
4. L O'Driscoll M Clynes 2006 Biomarkers and multiple drug resistance in breast cancer Curr Cancer Drug Targets 6 365 384 16918307 10.2174/ 156800906777723958 (Pubitemid 44033389)
5. BL Weber KL Nathanson 2000 Low penetrance gene associated with increased risk for breast cancer Eur J Cancer 36 1193 1199 10882856 10.1016/S0959-8049(00) 00082-4 1:CAS:528:DC%2BD3cXksFCrsr8%3D (Pubitemid 30407005)
6. C Campagnoli N Biglia C Cantamessa, et al. 1999 HRT and breast cancer risk: a clue for interpreting the available data Maturitas 33 185 190 10656496 10.1016/S0378-5122(99)00082-1 1:CAS:528:DyaK1MXns1Wgtr8%3D
7. M Ferno 1998 Prognostic factors in breast cancer: a brief review Anticancer Res 18 2167 2171 9703779 1:STN:280:DyaK1czmvFCjsA%3D%3D (Pubitemid 28386484)
8. KL Nathanson R Wooster BL Weber, et al. 2001 Breast cancer genetics: what we know and what we need Nat Med 7 552 556 11329055 10.1038/87876 1:CAS:528:DC%2BD3MXjsVakurs%3D (Pubitemid 32448321)
9. D Pham 2006 Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas J Clin Oncol 24 1700 1704 16505411 10.1200/JCO.2005.04.3224 1:CAS:528:DC%2BD28XksVKgtLY%3D (Pubitemid 46622141)
10. SY Lin 2001 Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat Cell Biol 3 802 808 11533659 10.1038/ncb0901-802 1:CAS:528:DC%2BD3MXmvF2ls74%3D (Pubitemid 32842685)
11. Y Lemos-Gonzalez 2007 Absence of activating mutations in the EGFR kinase domain in Spanish head and neck cancer patients Tumour Biol 28 273 279 17962724 10.1159/000110425 1:CAS:528:DC%2BD2sXhtlCgsbnF (Pubitemid 350165833)
12. MA Olayioye RM Neve HA Lane, et al. 2000 The ErbB signalling network: receptor heterodimerization in development and cancer EMBO J 19 3159 3167 10880430 10.1093/emboj/19.13.3159 1:CAS:528:DC%2BD3cXlt1ajtLY%3D (Pubitemid 30428195)
13. W Zhang J Stoehlmacher DJ Park, et al. 2005 Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer Clin Colorectal Cancer 5 124 131 16098254 10.3816/CCC.2005.n.025
14. I Kallel M Rebai A Khabir, et al. 2009 Genetic polymorphism in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia Biomed Biotechnol 10 1155 753683
15. MS Tsao A Sakurada JC Cutz, et al. 2005 Erlotinib in lung cancer-molecular and clinical predictors of outcome N Engl J Med 353 133 144 16014883 10.1056/NEJMoa050736 1:CAS:528:DC%2BD2MXmtFejt70%3D (Pubitemid 41058345)
16. F Cappuzzo FR Hirsch E Rossi, et al. 2005 Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 643 655 15870435 10.1093/jnci/dji112 1:CAS:528:DC%2BD2MXjvFymt70%3D (Pubitemid 40812628)
17. M Nomura 2007 Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers PLoS Med 4 e125 17455987 10.1371/journal.pmed.0040125 (Pubitemid 46658773)
18. R Bianco T Gelardi V Damiano, et al. 2007 Rational bases for the development of EGFR inhibitors for cancer treatment Int J Biochem Cell Biol 39 1416 1431 17596994 10.1016/j.biocel.2007.05.008 1:CAS:528:DC%2BD2sXnslWltb8%3D (Pubitemid 47031050)
19. G Merlinov N Ishii PJ Whang, et al. 1985 Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells Mol Cell Biol 5 1722 1734
20. BM Karin GS Caren BH Frank AR Bernard EH Susan AC Graham EM JoAnn 2003 Type 2 diabetes and subsequent incidence of breast cancer in the nurses' health study Diabetes Care 26 6 1752 1758 10.2337/diacare.26.6.1752 (Pubitemid 36929115)
21. EC Joanne AL Rod R Sue, et al. 2001 Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer Int J Cancer (Pred oncol) 95 271 275 10.1002/1097-0215(20010720)95:4<271::AID- IJC1046>3.0.CO;2-D (Pubitemid 32592096)
22. Clark JH, Schrader WT, O'Malley BW et al (1992) Mechanism of action of steroid hormone. In: Wilson JD, Foster DW (eds) Text book of endocrinology. W. B. Saunders, New York, pp 35-90
23. N Roodi LR Bailey WY Kao, et al. 1995 Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer J Natl Cancer Inst 87 446 451 7861463 10.1093/jnci/87.6.446 1:CAS:528: DyaK2MXkvVGntL4%3D
24. M Ferno 1998 Prognostic factors in breast cancer: a brief review Anticancer Res 18 2167 2171 9703779 1:STN:280:DyaK1czmvFCjsA%3D%3D (Pubitemid 28386484)
25. CK Osborne R Schiff SAW Fuqua, et al. 2001 Estrogen receptor: current understanding of its activation and modulation Clin Cancer Res 7 4338s 4342s 11916222 1:CAS:528:DC%2BD38XltlyjsA%3D%3D (Pubitemid 34031577)
26. W Zhang J Stoehlmacher DJ Park, et al. 2005 Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer Clin Colorectal Cancer 2 124 131 10.3816/CCC.2005.n.025
27. E Akisik N Dalay 2004 Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk Exp Mol Pathol 3 260 263 10.1016/j.yexmp.2003.12.005 (Pubitemid 38569788)
28. Collaborative Group on Hormonal Factors in Breast Cancer 2001 Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease Lancet 358 1389 1399 10.1016/S0140-6736(01)06524-2 (Pubitemid 33055739)
29. K McPherson CM Steel JM Dixon 2000 ABC of breast diseases. Breast cancer epidemiology, risk factors, and genetics BMJ 321 624 628 10977847 10.1136/bmj.321.7261.624 1:STN:280:DC%2BD3cvmvF2luw%3D%3D
30. SC Larsson CS Mantzoros A Wolk 2007 Diabetes mellitus and risk of breast cancer: a meta-analysis Int J Cancer 121 856 862 17397032 10.1002/ijc.22717 1:CAS:528:DC%2BD2sXotlequ7w%3D (Pubitemid 47106217)
31. E Papadopoulou K Simopoulos G Tripsianis, et al. 2007 Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer Neoplasma 54 5 365 373 17918664 1:CAS:528: DC%2BD1cXivVyhtw%3D%3D
32. NS Murthy K Chaudhry D Nadayil UK Agarwal S Saxena 2009 Changing trends in incidence of breast cancer: Indian scenario Indian J Cancer 46 73 74 19282574 10.4103/0019-509X.48603 1:STN:280:DC%2BD1M3gsFSjug%3D%3D
33. R Wooster BL Weber 2003 Breast and ovarian cancer N Engl J Med 348 339 2347
34. SA Narod 2002 Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2 113 123 12635174 10.1038/nrc726 (Pubitemid 37328798)
35. Chang-Claude J (2001) Inherited genetic susceptibility to breast cancer. In: Miller AB, Bartsch H, Boffeta P, Dragsted L, Vainio H (eds) Biomarkers in cancer prevention. Lyon, IARC, pp 177-190
36. RS Houlston IP Tomlinson 2000 Detecting low penetrance genes in cancer: the way ahead J Med Genet 37 161 167 10699050 10.1136/jmg.37.3.161 1:CAS:528:DC%2BD3cXit1Smsrs%3D (Pubitemid 30245908)
37. AM Dunning CS Healey PD Pharoah, et al. 1999 A systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomark Prev 8 843 854 1:CAS:528:DyaK1MXns1CrtLw%3D (Pubitemid 29508718)
38. SY Lin 2001 Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat Cell Biol 3 802 808 11533659 10.1038/ncb0901-802 1:CAS:528:DC%2BD3MXmvF2ls74%3D (Pubitemid 32842685)
39. AM Rebecca VM Elaine RK Margaret, et al. 2009 EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis Carcinogenesis 30 7 1155 1160 10.1093/carcin/bgp077
40. SH Young LD Sandra G Yu-Tang, et al. 2009 A two-stage case-control study of EGFR polymorphisms and breast cancer risk Cancer Epidemiol Biomarkers Prev 18 2 680 683 10.1158/1055-9965.EPI-08-0961
41. W Liu F Innocenti P Chen, et al. 2003 Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron I polymorphism Clin Cancer Res 9 1009 1012 12631599 1:CAS:528:DC%2BD3sXhvFKit7o%3D (Pubitemid 36323704)
42. C Carpentier F Laigle-Donadey Y Marie, et al. 2006 Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma Neurology 67 872 874 16885506 10.1212/01.wnl.0000229927.12007.37 1:CAS:528:DC%2BD28XoslOnurc%3D (Pubitemid 44403593)
43. Q Zhou 2006 EGFR Intron 1 polymorphism in Asian populations and its correlation with EGFR gene expression and amplification in breast tumor tissues Cancer Biol Ther 5 1445 1449 17102595 10.4161/cbt.5.11.3457 1:CAS:528: DC%2BD2sXksVyrtb0%3D
44. L Yaich WD Dupont DR Cavener, et al. 1992 Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood Cancer Res 52 77 83 1345763 1:CAS:528:DyaK38Xls1Cqug%3D%3D
45. FF Parl DR Cavener WD Dupont, et al. 1989 Genomic DNA analysis of the estrogen receptor gene in breast cancer Breast Cancer Res Treat 14 57 64 2575000 10.1007/BF01805976 1:STN:280:DyaK3c7gsFOmsA%3D%3D (Pubitemid 20023424)
46. TI Andersen KR Heimdal M Skrede, et al. 1994 Estrogen receptor (ESR) polymorphisms and breast cancer susceptibility Hum Genet 94 665 670 7989041 1:CAS:528:DyaK2MXjsF2jsbk%3D (Pubitemid 24351525)
47. A Shin SU Kim H Nishio, et al. 2002 Estrogen receptor and breast cancer risk Proc American Assoc Cancer Res 42 239
48. C Qiuyin S Xiao-Ou J Fan, et al. 2003 Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the shanghai breast cancer study Cancer Epidemiol Biomarkers 12 853 859
49. Y Shen DK Li J Wu, et al. 2006 Joint effects of the CYP1A1MspI, Era PvuII, and Era XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China Cancer Epidemiol Biomarkers Prev 15 2 342 347 16492926 10.1158/1055-9965.EPI-05-0485 1:CAS:528:DC%2BD28Xhs1Wrt7s%3D (Pubitemid 43342185)
50. JE Curran RA Lea S Rutherford, et al. 2001 Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer Int J Cancer 95 4 271 275 11400122 10.1002/1097-0215(20010720)95: 4<271::AID-IJC1046>3.0.CO;2-D 1:CAS:528:DC%2BD3MXlt1yqs74%3D (Pubitemid 32592096)
51. E Akisik N Dalay 2004 Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk Exp Mol Pathol 76 260 263 15126109 10.1016/j.yexmp.2003.12.005 1:CAS:528:DC%2BD2cXjs1CisrY%3D (Pubitemid 38569788)
52. N Roodi LR Bailey WY Kao, et al. 1995 Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer J Natl Cancer Inst X7 446 451 10.1093/jnci/87.6.446
53. TI Andersen KR Heimdal M Skrede, et al. 1994 Estrogen receptor (ESR) polymorphisms and breast cancer susceptibility Hum Genet 94 665 670 7989041 1:CAS:528:DyaK2MXjsF2jsbk%3D (Pubitemid 24351525)
54. S Lehrer E Levine P Savoretti, et al. 1992 Estrogen and progesterone receptor dissociation and familial history of breast cancer Lancet 339 1108 1109 1349117 10.1016/0140-6736(92)90697-2 1:STN:280:DyaK383js1anug%3D%3D
55. H Dotzlaw M Alkhalaf LC Murphy, et al. 1992 Characterization of estrogen receptor variant mRNAs from human breast cancers Mol Endocrinol 6 773 785 1603086 10.1210/me.6.5.773 1:CAS:528:DyaK3sXitFSgt7o%3D
56. TI Andersen KR Heimdal M Skrede, et al. 1994 Estrogen receptor (ESR) polymorphisms and breast cancer susceptibility Hum Genet 94 665 670 7989041 1:CAS:528:DyaK2MXjsF2jsbk%3D (Pubitemid 24351525)
57. E Weiderpass I Persson H Melhus, et al. 2000 Estrogen receptor a gene polymorphisms and endometrial cancer risk Carcinogenesis 21 623 627 10753195 10.1093/carcin/21.4.623 1:CAS:528:DC%2BD3cXivFKktLg%3D (Pubitemid 30214016)
58. HJ Kang SW Kim HJ Kim, et al. 2002 Polymorphisms in the estrogen gene and breast cancer risk Cancer Lett 178 175 180 11867202 10.1016/S0304-3835(01) 00861-8 1:CAS:528:DC%2BD38XhsFWhu7o%3D (Pubitemid 34178542)